Cargando…

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shishido, Stephanie N., Carlsson, Anders, Nieva, Jorge, Bethel, Kelly, Hicks, James B., Bazhenova, Lyudmila, Kuhn, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714097/ https://www.ncbi.nlm.nih.gov/pubmed/31462312 http://dx.doi.org/10.1186/s12967-019-2035-8

Ejemplares similares

A Stochastic Markov Chain Model to Describe Lung Cancer Growth and Metastasis
por: Newton, Paul K., et al.
Publicado: (2012)

An Observational Study of Circulating Tumor Cells and (18)F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
por: Nair, Viswam S., et al.
Publicado: (2013)

Entropy, complexity, and Markov diagrams for random walk cancer models
por: Newton, Paul K., et al.
Publicado: (2014)

Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series
por: Marrinucci, Dena, et al.
Publicado: (2010)

Plasticity of circulating tumor cells in small cell lung cancer
por: Seo, Jiyoun, et al.
Publicado: (2023)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
por: Giustini, Nicholas, et al.
Publicado: (2021)

Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells
por: Dago, Angel E., et al.
Publicado: (2014)

Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer
por: Gerdtsson, Anna S., et al.
Publicado: (2019)

Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones
por: Ndacayisaba, Libere J., et al.
Publicado: (2022)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
por: Yu, Li, et al.
Publicado: (2022)

New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
por: Villanueva, Nicolas, et al.
Publicado: (2018)

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial
por: Gettinger, Scott N., et al.
Publicado: (2021)

Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023)

Stage IV Non-small Cell Lung Cancer Presenting as Supraventricular Tachycardia
por: Amin, Hina, et al.
Publicado: (2019)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer
por: Cohen, Roger B, et al.
Publicado: (2014)

Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer
por: Green, Hannah Elizabeth, et al.
Publicado: (2021)

Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case
por: Chai, Shoujie, et al.
Publicado: (2022)

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)

Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms
por: Ndacayisaba, Libere J., et al.
Publicado: (2022)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
por: Cheruvu, Praveena, et al.
Publicado: (2011)

Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer
por: Tsigelny, Igor F., et al.
Publicado: (2015)

A Case of Small Cell Cancer of the Breast in a Male with Synchronous Stage IV Non-Small Cell Lung Carcinoma
por: Matt, Laurie, et al.
Publicado: (2013)

ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
por: Wang, Michelle, et al.
Publicado: (2023)

Practical Guidance for the Management of Adverse Events in Patients with KRAS(G12C)-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib
por: Zhang, Jun, et al.
Publicado: (2023)

When it comes to genomic analysis of tumours, don't buy in bulk
por: Nieva, Jorge, et al.
Publicado: (2018)

Long-term survival in a stage IV small cell carcinoma of the endometrium
por: Viau, M., et al.
Publicado: (2020)

PET/CT for staging and monitoring non small cell lung cancer
por: Rankin, Sheila
Publicado: (2008)

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
por: Thatcher, Nicholas, et al.
Publicado: (2010)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
por: Simonetti, Sara, et al.
Publicado: (2010)

Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
por: Yoo, Su Jin, et al.
Publicado: (2012)

Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
por: Dawson, Alan G, et al.
Publicado: (2015)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
por: Ando, Masahiko, et al.
Publicado: (1999)

Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
por: Badawy, Ahmed Ashour, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bhok12pqlda24q2jjfa65hk5jq